Zodiac Produtos Farmaceuticos S.a.
Clinical trials sponsored by Zodiac Produtos Farmaceuticos S.a., explained in plain language.
-
Could a cheaper copy of a key chemo drug work just as well?
Disease control CompletedThis study compares a new formulation of the chemotherapy drug doxorubicin (Doxopeg) to the standard version (Caelyx) in people with advanced ovarian cancer or metastatic breast cancer. The goal is to see if the two drugs are absorbed and processed by the body in the same way. Pa…
Phase 1 • Sponsor: Zodiac Produtos Farmaceuticos S.A. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a copycat epilepsy drug match the original? a trial puts it to the test
Knowledge-focused CompletedThis Phase 1 trial checks whether a new coated tablet containing brivaracetam delivers the same amount of the drug into the bloodstream as the reference product Briviact. Researchers give a single dose of each version to 28 healthy adults under fasting conditions and compare key …
Phase 1 • Sponsor: Zodiac Produtos Farmaceuticos S.A. • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Generic Alzheimer's patch put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked whether a new generic rivastigmine patch works as well as the brand-name Exelon® patch. Sixty-eight healthy adults wore each patch to compare how much medicine got into their blood and how well the patch stuck to the skin. The goal was to see if the generic ver…
Phase 1 • Sponsor: Zodiac Produtos Farmaceuticos S.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC